Verition Fund Management’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.14K Sell
19,971
-34,939
-64% -$32.2K ﹤0.01% 2170
2025
Q4
$121K Buy
+54,910
New +$88.4K ﹤0.01% 3285

Other funds holding GUTS

Verition Fund Management's GUTS Position: Q1 2026 in Review

Verition Fund Management reduced its Fractyl Health (GUTS) stake by 64% in Q1 2026, selling an estimated $32.2K and leaving 19,971 shares worth $9.14K. The position accounts for ﹤0.01% of the portfolio, ranked #2170.

Verition Fund Management first reported a position in GUTS in Q4 2025 and has held it in 2 quarters since. The position peaked at $121K in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • Verition Fund Management held 19,971 shares of Fractyl Health worth $9.14K as of Q1 2026.
  • Verition Fund Management sold 34,939 Fractyl Health shares in Q1 2026, an estimated $32.2K.
  • Fractyl Health made up ﹤0.01% of Verition Fund Management's portfolio in Q1 2026, its #2170 holding.
  • Verition Fund Management first reported a position in Fractyl Health in Q4 2025 and has held it in 2 quarters since.
  • Verition Fund Management's Fractyl Health position peaked at $121K in Q4 2025.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.